Status:
RECRUITING
MACSSI (MAstectomie Cellules Souches Surveillance Immunitaire)
Lead Sponsor:
Centre Leon Berard
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Monocentric, observational and prospective study in adult women having an early-stage breast cancer without genetic risk. The main objective is to characterize quantitatively and qualitatively, after...
Detailed Description
Breast cancer is one of the most frequent and the second cause of mortality for women in the world. Breast is a complex organ which has several changes (puberty, pregnancy and menopause). These modifi...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Patient requiring a breast surgery (total mastectomy) of an early stage tumour classified as :
- Luminal A (Arm A) : Patients with a moderate risk of breast cancer progression or,
- Luminal B or Basal (Arm B) : Patients with a high risk of breast cancer progression
- Systemic treatment not initiated
- Breast cup size ≥ C
- Informed and signed consent.
Exclusion
- Neo-adjuvant chemotherapy or hormonotherapy
- History of breast irradiation
- Pregnant or breastfeeding woman
- Patient under tutorship or curatorship
- Patient who underwent a lumpectomy with a level-2 oncoplastic surgery (ex: breast reduction with an inverted-T remodeling)
- Any other prior anti-tumor treatment
- Other medical pathology which may interfere with the biologic evaluation, especially chronic auto-immune diseases.
Key Trial Info
Start Date :
February 22 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 15 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03870802
Start Date
February 22 2021
End Date
November 15 2024
Last Update
January 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Léon Bérard
Lyon, France, 69008